157 related articles for article (PubMed ID: 27343468)
1. Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage.
Li Y; Qiu W; Zhang L; Fung J; Lin F
Biomaterials; 2016 Sep; 102():209-19. PubMed ID: 27343468
[TBL] [Abstract][Full Text] [Related]
2. Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration.
Li Y; Fung J; Lin F
Mol Ther; 2016 Sep; 24(9):1665-74. PubMed ID: 27377042
[TBL] [Abstract][Full Text] [Related]
3. Decoy nanoparticles bearing native C5a receptors as a new approach to inhibit complement-mediated neutrophil activation.
Li Y; Lin F
Acta Biomater; 2019 Nov; 99():330-338. PubMed ID: 31446047
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells are injured by complement after their contact with serum.
Li Y; Lin F
Blood; 2012 Oct; 120(17):3436-43. PubMed ID: 22966167
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cells Form 3D Clusters Following Intraventricular Transplantation.
Jungwirth N; Salinas Tejedor L; Jin W; Gudi V; Skripuletz T; Stein VM; Tipold A; Hoffmann A; Stangel M; Baumgärtner W; Hansmann F
J Mol Neurosci; 2018 May; 65(1):60-73. PubMed ID: 29705933
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells inhibit complement activation by secreting factor H.
Tu Z; Li Q; Bu H; Lin F
Stem Cells Dev; 2010 Nov; 19(11):1803-9. PubMed ID: 20163251
[TBL] [Abstract][Full Text] [Related]
9. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment.
Lu H; Wu X; Wang Z; Li L; Chen W; Yang M; Huo D; Zeng W; Zhu C
J Surg Res; 2016 Oct; 205(2):464-473. PubMed ID: 27664897
[TBL] [Abstract][Full Text] [Related]
11. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
[TBL] [Abstract][Full Text] [Related]
12. Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications.
Zhu M; He X; Wang XH; Qiu W; Xing W; Guo W; An TC; Ao LQ; Hu XT; Li Z; Liu XP; Xiao N; Yu J; Huang H; Xu X
Diabetologia; 2017 Sep; 60(9):1822-1833. PubMed ID: 28577176
[TBL] [Abstract][Full Text] [Related]
13. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
[TBL] [Abstract][Full Text] [Related]
14. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist.
Sewell DL; Nacewicz B; Liu F; Macvilay S; Erdei A; Lambris JD; Sandor M; Fabry Z
J Neuroimmunol; 2004 Oct; 155(1-2):55-63. PubMed ID: 15342196
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation.
Omoto M; Katikireddy KR; Rezazadeh A; Dohlman TH; Chauhan SK
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6631-8. PubMed ID: 25228546
[TBL] [Abstract][Full Text] [Related]
16. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
[TBL] [Abstract][Full Text] [Related]
17. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
[TBL] [Abstract][Full Text] [Related]
18. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients.
Jakobs FM; Davis EA; Qian Z; Liu DY; Baldwin WM; Sanfilippo F
Clin Transplant; 1997 Oct; 11(5 Pt 2):516-21. PubMed ID: 9361953
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells induce an inflammatory response after intravenous infusion.
Hoogduijn MJ; Roemeling-van Rhijn M; Engela AU; Korevaar SS; Mensah FK; Franquesa M; de Bruin RW; Betjes MG; Weimar W; Baan CC
Stem Cells Dev; 2013 Nov; 22(21):2825-35. PubMed ID: 23767885
[TBL] [Abstract][Full Text] [Related]
20. Real-Time Imaging of Interactions of Neutrophils with Cryptococcus neoformans Demonstrates a Crucial Role of Complement C5a-C5aR Signaling.
Sun D; Zhang M; Liu G; Wu H; Zhu X; Zhou H; Shi M
Infect Immun; 2016 Jan; 84(1):216-29. PubMed ID: 26502909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
